河北
分享至
来源：第一财经
诺和诺德美股盘前涨超4%。消息面上，诺和诺德宣布，公司已在美国正式推出全球首款用于成人减重的GLP-1口服药。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
